TBPH
13.80 USD
+1.78%
Today
-1.93%
1D
Last seen at Wed, 11 Mar 2026 22:39:00 GMT+3
Market is closed
Sun
Closed
Mon
3:31 PM ~ 9:59 PM
Tue
3:31 PM ~ 9:59 PM
Wed
3:31 PM ~ 9:59 PM
Thu
3:31 PM ~ 9:59 PM
Fri
3:31 PM ~ 9:59 PM
Sat
Closed
Performance
1 Day
- 1.93 %
1 Week
+ 0.50 %
1 Month
- 27.63 %
3 Month
- 20.33 %
6 Month
+ 2.87 %
1 Year
+ 48.51 %
Information
Name
Theravance Biopharma Inc Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
698.27M
Avg Daily Volume
1.08M
52 Week High
21.03 USD
52 Week Low
7.9 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). Its late-stage investigational once-daily norepinephrine reuptake inhibitor, Ampreloxetine is in the development for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Top News
South African rand weakens on escalating Middle East tensions ahead of local data
reuters.com
1h ago
AUDUSD
-0.33%
AUDJPY
-0.32%
EURUSD
-0.18%
EURAUD
+0.21%
USDJPY
+0.01%
NZDUSD
-0.10%
Australia dollar restrained by risk aversion, supported by rates
reuters.com
6h ago
EURUSD
-0.18%
USDJPY
+0.01%
XAUUSD
-0.16%
GLOBAL MARKETS-Stocks dip, Treasury yields jump as oil pushes higher
reuters.com
11h ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
